Excess body weight and obesity as a side effect of medications

Background . Drug-induced weight gain is a common adverse effect of many medications used in everyday clinical practice. It contributes to the overall picture of lipid metabolism disorders, may reduce adherence to treatment, including treatment discontinuation with relapse of the underlying disease, and increases the risk of hypertension, type II diabetes mellitus, cardiovascular complications and certain cancers. Objective . To summarize literature data on medications associated with overweight and obesity and to draw clinicians’ attention to drug-related causes of weight gain. Methods . A narrative review of the literature on drug-induced weight gain and obesity. Data on medications, mechanisms of weight gain and clinical consequences were analyzed and summarized. Key content and findings . Glucocorticosteroids, insulin, growth hormone, hormonal contraceptives, psychotropic medications (anticonvulsants, antidepressants, antipsychotics, anxiolytics and sedatives), antihypertensive drugs, antibacterial agents and combination antiretroviral therapy are discussed. Possible mechanisms are considered: increased appetite and altered food preferences, effects on leptin and neuropeptide Y, insulin resistance, reduced physical activity and lipolysis, and influence on the gut microbiota. It is emphasized that drug-induced obesity is not merely a cosmetic issue but is associated with comorbidity and worse prognosis. Conclusions . Drug-induced obesity is a multifactorial condition requiring clinicians’ awareness, timely detection of weight gain during pharmacotherapy and, when necessary, selection of drugs with a more favorable metabolic profile.

Authors

Institutions

Publication Details

Journal
Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
Published
2026-11-06
DOI
https://doi.org/10.37489/2588-0519-gcp-0042
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Excess body weight and obesity as a side effect of medications

Maria N. Kostyleva, A. N. Gratsianskaya, Постников Сергей Сергеевич, Natalia V. Teplova et al.
Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
Pharmacology and Obesity Treatment
article

Excess body weight and obesity as a side effect of medications

Maria N. Kostyleva, A. N. Gratsianskaya, Постников Сергей Сергеевич, Natalia V. Teplova, A. G. Jacksembekov, Белоусова Людмила Борисовна, Варданян Аргишти Гагикович
article en

Abstract

Background . Drug-induced weight gain is a common adverse effect of many medications used in everyday clinical practice. It contributes to the overall picture of lipid metabolism disorders, may reduce adherence to treatment, including treatment discontinuation with relapse of the underlying disease, and increases the risk of hypertension, type II diabetes mellitus, cardiovascular complications and certain cancers. Objective . To summarize literature data on medications associated with overweight and obesity and to draw clinicians’ attention to drug-related causes of weight gain. Methods . A narrative review of the literature on drug-induced weight gain and obesity. Data on medications, mechanisms of weight gain and clinical consequences were analyzed and summarized. Key content and findings . Glucocorticosteroids, insulin, growth hormone, hormonal contraceptives, psychotropic medications (anticonvulsants, antidepressants, antipsychotics, anxiolytics and sedatives), antihypertensive drugs, antibacterial agents and combination antiretroviral therapy are discussed. Possible mechanisms are considered: increased appetite and altered food preferences, effects on leptin and neuropeptide Y, insulin resistance, reduced physical activity and lipolysis, and influence on the gut microbiota. It is emphasized that drug-induced obesity is not merely a cosmetic issue but is associated with comorbidity and worse prognosis. Conclusions . Drug-induced obesity is a multifactorial condition requiring clinicians’ awareness, timely detection of weight gain during pharmacotherapy and, when necessary, selection of drugs with a more favorable metabolic profile.

Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice(3)
Pirogov Russian National Research Medical University (RU)
Openalex Percentile: Top 18%
Pharmacology and Obesity Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon